What do systematic reviews say?

Summary of findings table ‐ Providing information about the residents? fall risk vs usual care

The review found no eligible studies for this question.

• Interventions for preventing and reducing the use of physical restraints for older people in all long‐term care settings 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Health education vs usual care

Health education probably leads to higher received at least one vaccine compared with routine care (moderate certainty).

• Interventions for improving coverage of childhood immunisation in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
  RR 1.58 [1.21, 2.05]
  1 study · 228 participants
  Moderate

Immunisation outreach vs usual care

Immunisation outreach probably leads to higher proportion of children under 5 years of age fully immunised with all… compared with routine care (moderate certainty).

• Interventions for improving coverage of childhood immunisation in low‐ and middle‐income countries 2023 · Cochrane Headline outcomes only
  RR 6.66 [4.78, 9.28]
  1 study · 1242 participants
  Moderate

Pharmaceutical care vs usual care

It is very uncertain whether pharmaceutical care changes the proportion of patients with one or more potentially… compared with usual care (very low certainty).

• Interventions to improve the appropriate use of polypharmacy for older people 2023 · Cochrane Headline outcomes only
  RR 0.81 [0.68, 0.98]
  13 studies · 4534 participants
  Very low

Pharmaceutical care vs usual care

It is very uncertain whether pharmaceutical care changes the proportion of patients with one or more potential prescribing… compared with usual care (very low certainty).

• Interventions to improve the appropriate use of polypharmacy for older people 2023 · Cochrane Headline outcomes only
  RR 0.5 [0.27, 0.91]
  7 studies · 2765 participants
  Very low

Lipid‐lowering agent vs placebo or no treatment

Lipid‐lowering agent showed no clear difference in ipsilateral major or disabling stroke (only reported for two… compared with placebo or no treatment (low certainty).

• Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes only
  RR 0.36 [0.09, 1.53]
  5 studies · 2235 participants
  Low

Lipid‐lowering agent vs placebo or no treatment

Lipid‐lowering agent showed no clear difference in stroke‐related mortality (only reported for one study: CT scan, MRI… compared with placebo or no treatment (low certainty).

• Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes only
  RR 0.25 [0.03, 2.29]
  2 studies · 1366 participants
  Low

Lipid‐lowering agent vs placebo or no treatment

Lipid‐lowering agent showed no clear difference in adverse events (only reported for two studies: one study used CT… compared with placebo or no treatment (low certainty).

• Pharmacological interventions for asymptomatic carotid stenosis 2023 · Cochrane Headline outcomes only
  RR 0.76 [0.53, 1.1]
  7 studies · 3726 participants
  Low

Intervention not reported

The intervention showed no clear difference in all‐cause hospital admission (number of participants with at least… (low certainty).

• Social network interventions to support cardiac rehabilitation and secondary prevention in the management of people… 2023 · Cochrane Headline outcomes only
  RR 1.03 [0.86, 1.22]
  2 studies · 258 participants
  Low

Intervention not reported

The intervention showed no clear difference in cardiovascular‐related hospital admission (number of participants… (low certainty).

• Social network interventions to support cardiac rehabilitation and secondary prevention in the management of people… 2023 · Cochrane Headline outcomes only
  RR 0.92 [0.77, 1.1]
  2 studies · 2583 participants
  Low

Intervention not reported

The review found no eligible studies for this question.

• Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine‐device use 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings for education vs control

It is very uncertain whether summary of findings for education changes number of people who experienced one or more falls compared with control (very low certainty).

• Interventions for preventing falls in Parkinson's disease 2022 · Cochrane Headline outcomes only
  Risk ratio 10.89 [1.26, 94.03]
  1 study · 53 participants
  Very low

Summary of findings for education vs control

The review found no eligible studies for this question.

• Interventions for preventing falls in Parkinson's disease 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Exercise vs control

Summary of findings for exercise showed no clear difference in number of people who experienced one or more falls compared with control (moderate certainty).

• Interventions for preventing falls in Parkinson's disease 2022 · Cochrane Headline outcomes only
  Risk ratio 0.9 [0.8, 1]
  9 studies · 932 participants
  Moderate

Summary of findings for exercise plus education vs control

Summary of findings for exercise plus education showed no clear difference in number of people who experienced one or more falls compared with control (low certainty).

• Interventions for preventing falls in Parkinson's disease 2022 · Cochrane Headline outcomes only
  Risk Ratio 0.89 [0.75, 1.07]
  3 studies · 352 participants
  Low

Summary of findings for exercise plus education vs control

It is very uncertain whether summary of findings for exercise plus education changes number of people sustaining one or more fall‐related fractures compared with control (very low certainty).

• Interventions for preventing falls in Parkinson's disease 2022 · Cochrane Headline outcomes only
  Risk ratio 1.45 [0.4, 5.32]
  2 studies · 320 participants
  Very low

Exercise vs control

It is very uncertain whether summary of findings for exercise changes number of people sustaining one or more fall‐related fractures compared with control (very low certainty).

• Interventions for preventing falls in Parkinson's disease 2022 · Cochrane Headline outcomes only
  Risk ratio 0.57 [0.28, 1.17]
  5 studies · 989 participants
  Very low

Summary of findings for cholinesterase inhibitors vs placebo

• Interventions for preventing falls in Parkinson's disease 2022 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 230 participants
  Very low

Summary of findings for cholinesterase inhibitors vs placebo

• Interventions for preventing falls in Parkinson's disease 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 23 participants
  Very low

Intervention not reported

The intervention showed no clear difference in death at one year (low certainty).

• Interventions for renal vasculitis in adults 2020 · Cochrane Headline outcomes only
  RR 1.04 [0.57, 1.92]
  5 studies · 267 participants
  Low